国产精华推荐2021,欧美性BBBBBXXXXXXX,国产乱妇无乱码大黄aa片,国产97在线 | 中文

當(dāng)前位置:首頁  >  技術(shù)文章  >  EPHA3可能是一種新的預(yù)后生物標(biāo)志物并與膀胱癌免疫浸潤相關(guān)

EPHA3可能是一種新的預(yù)后生物標(biāo)志物并與膀胱癌免疫浸潤相關(guān)

更新時(shí)間:2024-12-28  |  點(diǎn)擊率:114

20231月,汕頭大學(xué)醫(yī)學(xué)院第二附屬醫(yī)院泌尿外科;廣州醫(yī)科大學(xué)第五附屬醫(yī)院泌尿外科;中山大學(xué)第一附屬醫(yī)院泌尿外科 (Department of Urology, The Second Affiliated Hospital of Shantou University, Medical College,Shantou 515041, ChinaDepartment of Urology, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou 510700, China;Department of Urology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510080, China) Hao Lin老師研究團(tuán)隊(duì)在《Cancers》上發(fā)表論文:

EPHA3 Could Be a Novel Prognosis Biomarker and Correlates with Immune Infiltrates in Bladder Cancer"

 

EPHA3可能是一種新的預(yù)后生物標(biāo)志物并與膀胱癌免疫浸潤相關(guān)"

 

Abstract

Purpose: To assess the mechanism of EPH receptor A3 (EPHA3) and its potential value for immunotherapy in BLCA.

Materials and methods: The Cancer Genome Atlas (TCGA) bladder cancer (BLCA) database and the Gene Expression Omnibus (GEO) database were used for assessing whether EHPA3 could be used to predict BLCA prognosis. This work carried out in vitro and in vivo assays for exploring how EPHA3 affected the biological behaviors. The downstream pathway was explored using a Western blotting technique. The CIBERSORT, ESTIMATE, TIMER, and TIDE tools were used to predict the immunotherapy value of EPHA3 in BLCA.

Results: EPHA3 was poorly expressed in BLCA (p < 0.05), its high expression is related to a good survival prognosis (p = 0.027 and p = 0.0275), and it has a good predictive ability for the histologic grade and status of BLCA (area under curve = 0.787 and 0.904). Overexpressed EPHA3 could inhibit BLCA cell biological behaviors, and it be associated with the downregulation of the Ras/pERK1/2 pathway. EPHA3 was correlated with several immune-infiltrating cells and the corresponding marker genes.

Conclusions: EPHA3 could be regarded as an acceptable anti-cancer biomarker in BLCA. EPHA3 plays an inhibiting role in BLCA, and it could be the candidate immunotherapeutic target for BLCA.


摘要:

目的:探討EPH受體A3 (EPHA3)的作用機(jī)制及其在BLCA免疫治療中的潛在價(jià)值。材料與方法:采用Cancer Genome Atlas (TCGA)膀胱癌(BLCA)數(shù)據(jù)庫和Gene Expression Omnibus (GEO)數(shù)據(jù)庫評估EHPA3是否可用于預(yù)測BLCA預(yù)后。本工作通過體外和體內(nèi)實(shí)驗(yàn)探討EPHA3對生物行為的影響。使用Western blotting技術(shù)探索下游途徑。采用CIBERSORT、ESTIMATE、TIMERTIDE工具預(yù)測EPHA3BLCA中的免疫治療價(jià)值。結(jié)果:EPHA3BLCA中表達(dá)較低(p < 0.05),其高表達(dá)與較好的生存預(yù)后相關(guān)(p = 0.027p = 0.0275),對BLCA的組織學(xué)分級和狀態(tài)有較好的預(yù)測能力(曲線下面積分別為0.7870.904)EPHA3過表達(dá)可抑制BLCA細(xì)胞的生物學(xué)行為,并與Ras/pERK1/2通路下調(diào)有關(guān)。EPHA3與多種免疫浸潤細(xì)胞及相應(yīng)的標(biāo)記基因相關(guān)。結(jié)論:EPHA3可作為BLCA的一種可接受的抗癌生物標(biāo)志物。EPHA3BLCA中具有抑制作用,可能成為BLCA的候選免疫治療靶點(diǎn)。

 

該論文中,人類膀胱癌細(xì)胞(5637、UMUC-3T24)以及正常的人類尿上皮細(xì)胞(SVHUC)的體外培養(yǎng)是使用Ausbian特級胎牛血清完成的。


亚洲精品日韩一区二区电影| 人人妻人人爽人人澡欧美一区| 性XXXXX大片免费视频| 欧美牲交a欧美牲交| 日本55丰满熟妇厨房伦| 无码综合天天久久综合网色吧影院| 777午夜精品久久av蜜臀| 亚洲不卡无码AV中文字幕| 人妻被黑人猛烈进入a片| 护士奶头又白又大又好摸视频| 99热这里有精品| 无码乱码av天堂一区二区| 亚洲色欲色欲www| 大胆顶级欧美艺术图片| 亚洲人成无码网站在线观看| 国产性生交XXXXX免费| 人鲁交yazhonghucxx| 久久久久亚洲av片无码下载蜜桃| 人人爽久久爱夜夜躁| 人妻夜夜添夜夜无码av| 国产a级毛片久久久久久精品| 久久精品免视看国产成人不卡| 99精品免费久久久久久久久日本 | 亂倫近親相姦中文字幕| 久久久久精品国产三级| 欧洲熟妇色xxxx欧美老妇多毛 | 亚洲AV无码有乱码在线观看| 免费无码国产欧美久久18| 人人妻人人澡人人爽人人精品浪潮| 久久人人爽人人爽人人片AV超碰| 日产精品99久久久久久| 成人无码区在线观看| 久久精品中文字幕一区| 精品人妻无码一区二区三区手机版| 97人妻精品全国免费视频| videosgrati欧美另类| 亚洲一区二区av在线观看| 麻豆影视在线直播视频| 欧美乱强伦XXXXX高潮| 日韩精品久久久久久久电影蜜臀| 无码欧美熟妇人妻影院欧美潘金莲|